Furthermore, MTRNR2L12 pseudo‐gene, HBB, and SPDYC were already reported as possible prognostic markers in breast cancer, where their overexpression in tumor cells led to unfavorable prognosis [40, 41, 42, 43]. This evidence concerns the gene HBB and breast carcinoma.